Next Article in Journal
Correction: Kostev, K.; Cai, T. Cystitis and Utipro® Plus: Real-World Evidence. Healthcare 2023, 11, 2564
Previous Article in Journal
Oral Adverse Events Associated with BRAF and MEK Inhibitors in Melanoma Treatment: A Narrative Literature Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 12
Issue 1
10.3390/healthcare12010107
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Death Anxiety in Caregivers of Chronic Patients

by
Raúl Quevedo-Blasco
1,*,
Amparo Díaz-Román
2 and
Alberto Vega-García
3
1
Mind, Brain and Behavior Research Center (CIMCYC), University of Granada, 18011 Granada, Spain
2
Faculty of Psychology and Speech Therapy, University of Málaga, 29010 Málaga, Spain
3
Campus de Chamartín, University Alfonso X El Sabio, 28016 Madrid, Spain
*
Author to whom correspondence should be addressed.
Healthcare 2024, 12(1), 107; https://doi.org/10.3390/healthcare12010107
Submission received: 25 October 2023 / Revised: 26 November 2023 / Accepted: 22 December 2023 / Published: 2 January 2024
Browse Figures
Review Reports Versions Notes

Abstract

:
This study aimed to determine the extent to which caregivers of patients with chronic illnesses experience death anxiety, and which variables from caregivers and patients might potentially be related to their death anxiety. It also aimed to compare the levels of death anxiety between patients and caregivers. Web of Science, Scopus, PubMed, Psychology Database, Cochrane, and Google Scholar were searched for original studies available until December 2022 that quantitatively addressed death anxiety in family and informal caregivers of individuals with chronic illnesses. The methodological quality of the included studies was assessed, and a meta-analysis was conducted using Hedges’ g as the effect size index and the DerSimonian–Laird method to analyze differences between patients and caregivers in death anxiety. The results of the 11 included studies showed moderate levels of death anxiety in caregivers, and the meta-analysis (k = 7; 614 patients and 586 caregivers) revealed non-significant differences between the death anxiety experienced by patients and caregivers (pooled Hedges’ g = −0.03, 95% CI = −0.29 to 0.25, p = 0.802). Some sociodemographic and psychological factors (e.g., gender, depression, and anxiety) might be related to the death anxiety experienced, but additional research is necessary to validate these findings.

1. Introduction

Humans are the only known species up to this moment that has the ability to contemplate and anticipate their own death [1]. They are destined to live life knowing that, sooner or later, they will die. In this way, death becomes the only certainty in their life. However, curiously, thanatophobia or death anxiety remains a central and common theme in the human experience [2] considered as a specific phobia.
Fears of death have accompanied individuals from their beginnings, frequently appearing in art, philosophy, literature, and cultural and religious practices [3]. There is indeed evidence that humans have grappled with death anxiety since the history of our species began to be recorded [4]. Nevertheless, there is no consensus on what happens or why death induces and provokes such anxiety [5]. Furthermore, to this day, it is well-documented that there continues to be a considerable degree of ambiguity regarding the concept of death [6]. It is such a multifaceted construct, studied from such diverse perspectives, that it becomes very difficult to define. The interchangeable use of the terms anxiety and fear has also contributed to the current confusion and difficulties in its definition [7]. Despite this, it has been conceptualized to include the concern, fear, or discomfort that arises after an individual becomes aware of their own death and the death of others [7,8,9]. In summary, considering the various perspectives, death anxiety can be defined as: “an unpleasant emotion of multidimensional concerns that is of an existential origin provoked on contemplation of death of self or others” (p. 413; [7]).
Terror Management Theory (TMT) has been the central theoretical approach guiding research on the impact of death anxiety in a wide range of phenomena over the last four decades [3,10]. TMT proposes that innate human instincts for self-preservation, along with the awareness of our own mortality, can produce a powerful sense of fear or meaninglessness, leading to a range of maladaptive coping behaviors [11]. Some of these behaviors, such as avoidance, can be the basis for numerous mental illnesses, while others may appear unrelated to death [12].
In this regard, although TMT research has largely focused on exploring the role of death anxiety in everyday human behavior, the findings also have significant implications for mental health, where it has recently been theorized that death anxiety is a transdiagnostic construct underpinning a multitude of mental illnesses [13]. Thus, death anxiety and its related symptoms could manifest in numerous disorders such as somatic and related disorders [14], panic disorder [15], specific phobias [12], obsessive-compulsive disorder [16,17], depressive disorders [18], post-traumatic stress disorder [19], or eating disorders [20]. It is important not to overlook the consideration of factors associated with suicide [21] and the proper diagnosis of suicidal ideation and intention (see [22]).
The findings from hundreds of studies have demonstrated the robustness of this theory [23,24]. These also have implications for clinical populations [3]. Individuals facing their own mortality when diagnosed with a chronic illness may suffer from death anxiety [25,26], making it one of the most common psychological consequences of chronic illnesses [27,28]. While many of these conditions are treatable today, the myriad of physical and psychological barriers that can arise over the course of the illness can intensify death anxiety [29,30]. Additionally, many of these patients facing life-threatening traumas and conditions experience death in institutional settings [31]. Here, nurses and other healthcare professionals caring for these patients may also have death-related fears, which can negatively influence their attitudes toward providing care [32,33].
The increase in patients with chronic illnesses requiring care and advances in medicine have led institutional care to give way to home care, which inevitably increases the number of caregivers—whether they are family members, spouses, friends, or home health aides—in a home environment [34]. Moreover, many of these illnesses come with significant deterioration, necessitating that patients increasingly depend on the assistance of these caregivers [35]. Being in close contact with the patient and observing their pain and physical decline, in addition to having serious implications for the caregiver, including increased financial, emotional, and physical burdens [36,37], can also trigger their own fears of death and dying [38]. In this context of chronic illness, where it becomes more common to witness the death of a loved one or think about leaving behind family or close individuals, the impact of death anxiety on caregivers has received increasing attention since the turn of the century [39]. However, literature on the subject remains limited [40,41].

Objectives

The main objective of this systematic review was to determine the extent to which caregivers of patients with chronic illnesses experience death anxiety, particularly in cases where the patients suffered from severe, life-threatening, or lethal chronic diseases. It also aimed to compare the death anxiety experienced by these caregivers with that experienced by the patients themselves and analyze potential variables from both the caregiver and the patient that may influence their levels of anxiety.

2. Materials and Methods

2.1. Literature Search

The systematic review (PROSPERO registration no: CRD42023487929) was conducted following the guidelines for the development and reporting of systematic reviews in Psychology and Health by [42] and the recommendations from the updated PRISMA 2020 guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses; [43]). A literature search was conducted in December 2022 (in accordance with some recommendations available for that purpose in the literature [44]) in the following databases: Web of Science (Core Collection), Scopus, PubMed, Psychology Database (via ProQuest, Ann Arbor, MI, USA; Clarivate), and Cochrane. Additionally, this search was supplemented with Google Scholar, and the references of the selected studies were reviewed to ensure that no research had evaded the filter. Combinations of structured keywords in English were used, replicating the search strategy: (“death anxiety” OR “fear of death” OR thanatophobia) AND (caregiver* OR spouse* OR family). The search was restricted to title, abstract, and/or keywords, with the search strategy adapted to the criteria of each database. Search limits were set for the year of publication (from 2010 to December 2022), publication type (articles and reviews), and language (English and Spanish).

2.2. Inclusion Criteria

Regarding the inclusion criteria, studies that addressed death anxiety in family and informal caregivers of individuals with severe or lethal chronic illnesses were selected, without restrictions on age, gender, country of origin, or religious belief. Only those studies in which the variable of death anxiety had been quantitatively measured in the population of interest and published in English or Spanish were included.
In terms of exclusion criteria, studies that did not adequately detail or investigate the psychological effects of death anxiety in caregivers were discarded. Studies in which the patients did not have chronic illnesses or in which the sample was mixed with patients with non-chronic illnesses were also excluded. Qualitative or incomplete studies, book chapters, conference abstracts, doctoral theses, and studies published in languages other than Spanish or English were rejected.

2.3. Selection Process

All search results from the various databases were exported to the bibliographic management software Mendeley Reference Manager for Desktop, and duplicates were manually removed. Both the initial selection of studies by title and abstract and the full-text review of the initially preselected studies were carried out by the first author of this article and an external reviewer. The results from both reviewers were compared, and discrepancies and uncertainties were resolved through consensus. The inter-rater reliability was calculated using Cohen’s kappa index.

2.4. Methodological Quality Assessment

The assessment of the methodological quality of the studies was conducted using the JBI Critical Appraisal Checklist for Analytical Cross-Sectional Studies by [45], with the exception of one randomized controlled trial [46] and an experimental study [47]. The former was evaluated using the JBI Critical Appraisal Tool for Assessment of Risk of Bias for Randomized Controlled Trials, as outlined by [48]. The experimental study, which investigated the impact of Rational Emotive Therapy adapted for palliative care on a sample of cancer patients and their family caregivers in Nigeria, was assessed using the CONSORT statement [49]. The criterion followed to choose one assessment tool over another was the study design of the included studies. Following the application of these assessment tools, it was confirmed that the articles included in this review exhibited medium to high quality, and thus, no documents were excluded based on quality criteria.

2.5. Method for Analysis and Synthesis of Information

For the data extraction from the selected articles, a template was used, which included: (a) the first author’s last name and year of publication, (b) total sample size, (c) the type of patient’s disease, (d) the country where the study was conducted, (e) study variables in the caregiver, (f) instruments used, and (g) primary results. Due to the variability of data provided by the studies, only one meta-analysis comparing death anxiety levels experienced by patients and caregivers was conducted, while the remaining study results were analyzed descriptively.
The meta-analysis was conducted using RStudio software (version 2021.09.0 + 351 for Windows). The small-sample adjusted standardized mean difference (Hedges’ g) was used as the effect size index, comparing the means and standard deviations of death anxiety obtained by patients and caregivers in a questionnaire or scale. The weighted effect size was calculated using the inverse variance method and the DerSimonian-Laird random-effects model, with a 95% confidence interval. Heterogeneity among the studies was assessed using the Q and I2 statistics. Sensitivity or publication bias analyses were not performed due to the limited number of selected studies.

3. Results

3.1. Study Selection

A total of 915 records were retrieved, and 192 duplicates were manually removed, resulting in the evaluation of 723 titles and abstracts for inclusion in the systematic review. In the initial screening, based on titles and abstracts, 33 studies were retained and subjected to full-text review, of which 11 were included in the systematic review. Figure 1 displays both the study selection process and the reasons for excluding studies reviewed in full text. The inter-rater reliability was excellent (κ = 1). The results of the methodological quality assessment indicated that the included studies did not show methodological biases.

3.2. Study Characteristics

The main characteristics of each study can be found in Table 1 and Table 2. The 11 included studies provided a total sample of 1836 caregivers. Among the caregivers, 747 (40.69%) were male, and 1089 (59.31%) were female. Cancer was the most common chronic illness among the patients in seven of the 11 studies, although of different types. Brain tumor, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Acquired Immunodeficiency Syndrome (AIDS) were the chronic illnesses in the remaining four studies.

3.3. Death Anxiety and Related Factors

The Death Anxiety Scale (DAS; [51]) was the most commonly used instrument in the analyzed studies, with various versions employed (e.g., Thorson-Powell’s DAS [60]). Other tests used in the rest of the studies included were the BOFRETTA scale [55], the Carmel’s Fear of Death and Dying Inventory [53], the Death and Dying Distress Scale-Caregivers (DADDS-CG; [62]), and the Death Anxiety Questionnaire (DAQ; [56]). The average scores on death anxiety varied among the studies, even when using the same assessment instrument (e.g., [50,57]). See specific information for each study in Table 1.
Regarding factors associated with death anxiety, it can be observed that depression and anxiety are among the most prevalent [35], although with nuances in some cases [52]. On the positive side, the relationship with patients’ performance and dependence can also be noted, although it negatively affects their quality of life and self-control [28,46,57]. Perceived social support is also identified as an explanatory factor for greater or lower levels of death anxiety in some studies [59]. It also varies depending on the illness, as exemplified in the study of Willis et al. [61], where this anxiety was notably high in female caregivers of terminally ill patients. Lastly, the strong correlation found in one study [50], between this type of anxiety and post-traumatic growth cannot be ignored. See Table 2 for further details of each study.
Considering the demographic characteristics of the participants, the variables most related to death anxiety were gender (n = 11), age (n = 11), marital status (n = 7), educational level (n = 7), and employment status (n = 6). In this regard, female gender was the only risk factor for high death anxiety scores in the study of Alkan et al. [50]. Other aspects considered in various studies, as an example, included socioeconomic status or monthly income (n = 3 and n = 1, respectively), religion (n = 2), living environment (n = 1), or type of housing (n = 1). The most noteworthy psychological consequences are primarily found in religious caregivers [50,52]. See Table 2 for details on the characteristics analyzed in each study and the instruments employed.

3.4. Comparison of Death Anxiety between Patients and Caregivers

The results of the meta-analysis conducted with seven of the included studies (Figure 2) did not reveal statistically significant differences in death anxiety levels experienced by patients and caregivers (pooled Hedges’ g = −0.03, 95% CI = −0.29 to 0.25, p = 0.802). There was high heterogeneity among the studies (Q = 24.17, p < 0.001, I2 = 75.18%).

4. Discussion

The fear of death is common to the human species [63], being more evident in cases of patients diagnosed with a life-threatening or terminal illness [64], and even more so in the case of its recurrence [54]. In the case of caregivers, there are fewer studies available; therefore, this review sought to determine whether this assertion can also be applied to caregivers of patients with chronic diseases. In this regard, it is essential to consider the existing mediation models in the perceptions of caregivers and, in general, healthcare professionals (see [65]).
The DAS developed by Templer [51] over 50 years ago, remains a classic test for assessing anxiety related to existential concerns about mortality. Even today, as evidenced by the results found, despite sustained contributions to research and instrumentation in this field, it continues to be a tool used to assess attitudes towards death in the literature [66].
Considering sociodemographic factors, only in two studies were higher levels of death anxiety found in women [28,61], indicating that it is not an exclusive risk variable (see Table 2). This could be due to the fact that this relationship only occurs in very specific areas or contexts and not universally across all settings [67,68].
When caregivers confront the process of death, pain, and the fear of mortality in patients during the care process, it can impact their quality of life [69,70]. These results are consistent with those found in the analyzed studies [28,46,57,58]. An interesting finding is that, after the meta-analytical analysis of seven studies, no statistically significant differences were found in the levels of death anxiety experienced by patients and caregivers. These results provide evidence of the importance of evaluating and working in a multidisciplinary way, not only with patients but also with caregivers. Additionally, this is a guarantee of effectiveness, as the caregiver’s quality of life is essential for the well-being of the patient who requires their care and attention. To achieve this, it is crucial to take into account and alleviate, to the extent possible, the caregiver burden, especially the emotional burden [71,72].
It is important to remember that, even though this work focuses on chronic patients, it is essential to also consider caregivers of patients with other disabilities or in special circumstances. For example, children with disabilities [73] or patients in institutional settings [31], where thoughts of suicide may even arise [74], or where individuals may already have specific needs, regardless of their physical health [75]. Notably, all professionals dealing with them could be at risk of psychological issues, not only those formally recognized as caregivers, and they also require attention and support [76]. This once again emphasizes the need to consider the professional profiles most associated with suicide in general [77], as well as the different situations that healthcare professionals, in particular, have to face (e.g., [78]), and underscores the importance of exploring pathways to promote their own health [65,79].
When drawing conclusions consistent with the results obtained in this study, caution is warranted, as it is not without limitations. The examined studies are limited in number, and there are methodological variables that may affect the generalization of the data. In this regard, it would be important to have a larger volume of studies using larger, and as homogenous as possible, samples. Moreover, there is a possibility that the included information may not be complete, as only studies in Spanish or English were included, potentially omitting relevant research in other languages. Similarly, research that may be significant in this field but did not meet the inclusion criteria or is indexed in other more complementary databases or institutional repositories may not have been considered. These limitations, however, further emphasize the need to delve deeper into the study of death anxiety in caregivers, whether of chronic patients or not.

5. Conclusions

In summary, the studies analyzed in this systematic review highlight that, in general, caregivers of patients with chronic diseases experience significant levels of death anxiety. According to the results of our meta-analysis, these levels may not even differ from those experienced by the patients themselves. Various sociodemographic and psychological factors, such as gender, and depression and anxiety levels, could influence the extent of death anxiety experienced by these caregivers. However, many more studies are still needed to examine this issue, considering the negative impact that death anxiety has on the quality of life of both caregivers and patients.
Research on the effects of death anxiety in this population is also demanded, in order to gain a deeper understanding of the impact of these symptoms on the care that they provide to the patients with chronic illnesses. This would assist researchers and clinicians in the development and implementation of more effective psychological management tools tailored to the needs of each caregiver, taking into account both their personal variables and those associated with the patient.

Author Contributions

Conceptualization, A.V.-G. and R.Q.-B.; methodology, R.Q.-B. and A.D.-R.; software, A.D.-R.; validation, A.V.-G., R.Q.-B. and A.D.-R.; formal analysis, A.D.-R.; investigation, R.Q.-B. and A.V.-G.; resources, A.V.-G., R.Q.-B. and A.D.-R.; data curation, R.Q.-B. and A.D.-R.; writing—original draft preparation, A.V.-G. and R.Q.-B.; writing—review and editing, R.Q.-B. and A.D.-R.; visualization, R.Q.-B. and A.D.-R.; supervision, R.Q.-B.; project administration, A.V.-G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data available on request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Yalom, I.D. Staring at the sun: Overcoming the terror of death. Humanist. Psychol. 2008, 36, 283–297. [Google Scholar] [CrossRef]
  2. Becker, E. The Denial of Death; Free Press: New York, NY, USA, 1973. [Google Scholar]
  3. Menzies, R.E.; Zuccala, M.; Sharpe, L.; Dar-Nimrod, I. The effects of psychosocial interventions on death anxiety: A meta-analysis and systematic review of randomised controlled trials. J. Anxiety Disord. 2018, 59, 64–73. [Google Scholar] [CrossRef] [PubMed]
  4. Menzies, R.E. Impermanence and the human dilemma: Observations across the ages. In Curing the Dread of Death: Theory, Research and Practice; Menzies, R.E., Menzies, R.G., Iverach, L., Eds.; Australian Academic Press: Sydney, Australia, 2018; pp. 3–21. [Google Scholar]
  5. Nyatanga, B. Is fear of death itself a rational preoccupation? Int. J. Palliat. Nurs. 2005, 11, 643–645. [Google Scholar] [CrossRef] [PubMed]
  6. Lotfifar, B.; Ghadampour, E.; Bagheri, N. Comparative effectiveness of psychotherapy approaches on Death Anxiety in Multiple Sclerosis Patients. A pilot randomized controlled trial. Mult. Scler. Relat. Disord. 2021, 51, 102914. [Google Scholar] [CrossRef] [PubMed]
  7. Nyatanga, B.; de Vocht, H. Towards a definition of death anxiety. Int. J. Palliat. Nurs. 2006, 12, 410–413. [Google Scholar] [CrossRef] [PubMed]
  8. MacLeod, R.; Crandall, J.; Wilson, D.; Austin, P. Death anxiety among New Zealanders: The predictive role of gender and marital status. Ment. Health Relig. Cult. 2016, 19, 339–349. [Google Scholar] [CrossRef]
  9. Soleimani, M.A.; Bahrami, N.; Zarabadi-Pour, S.; Motalebi, S.A.; Parker, A.; Chan, Y.H. Predictors of death anxiety among patients with heart disease. Death Stud. 2018, 44, 160–167. [Google Scholar] [CrossRef] [PubMed]
  10. Jong, J. Death anxiety and religion. Curr. Opin. Psychol. 2021, 40, 40–44. [Google Scholar] [CrossRef]
  11. Rosenblatt, A.; Greenberg, J.; Solomon, S.; Pyszczynski, T.; Lyon, D. Evidence for terror management theory: I. The effects of mortality salience on reactions to those who violate or uphold cultural values. J. Pers. Soc. Psychol. 1989, 57, 681–690. [Google Scholar] [CrossRef]
  12. Menzies, R.E.; Menzies, R.G. Death anxiety in the time of COVID-19: Theoretical explanations and clinical implications. Cogn. Behav. Ther. 2020, 13, e19. [Google Scholar] [CrossRef]
  13. Iverach, L.; Menzies, R.G.; Menzies, R.E. Death anxiety and its role in psychopathology: Reviewing the status of a transdiagnostic construct. Clin. Psychol. Rev. 2014, 34, 580–593. [Google Scholar] [CrossRef] [PubMed]
  14. Furer, P.; Walker, J.R.; Stein, M.B. Treating Health Anxiety and Fear of Death: A Practitioner’s Guide; Springer Science + Business Media, LLC: New York, NY, USA, 2007. [Google Scholar]
  15. Starcevic, V. Body as the source of threat and fear of death in hypochondriasis and panic disorder. Psihijatr. Danas. 2007, 39, 73–82. [Google Scholar]
  16. Menzies, R.G.; Menzies, R.E.; Iverach, L. The role of death fears in Obsessive Compulsive Disorder. Aust. Psychol. Soc. 2015, 1, 6–11. [Google Scholar]
  17. Menzies, R.E.; Dar-Nimrod, I. Death anxiety and its relationship with obsessive-compulsive disorder. J. Abnorm. Psy. 2017, 126, 367–377. [Google Scholar] [CrossRef] [PubMed]
  18. Ghaemi, S.N. Feeling and Time: The Phenomenology of Mood Disorders, Depressive Realism, and Existential Psychotherapy. Schizophr. Bull. 2007, 33, 122–130. [Google Scholar] [CrossRef] [PubMed]
  19. Chatard, A.; Pyszczynski, T.; Arndt, J.; Selimbegović, L.; Konan, P.N.; Van der Linden, M. Extent of trauma exposure and PTSD symptom severity as predictors of anxiety-buffer functioning. Psychol. Trauma: Theory Res. Pract. 2012, 4, 47–55. [Google Scholar] [CrossRef]
  20. Farber, S.K.; Jackson, C.C.; Tabin, J.K.; Bachar, E. Death and annihilation anxieties in anorexia nervosa, bulimia, and self-mutilation. Psychoanal. Psychol. 2007, 24, 289–305. [Google Scholar] [CrossRef]
  21. Cano-Montalbán, I.; Quevedo-Blasco, R. Sociodemographic Variables Most Associated with Suicidal Behaviour and Suicide Methods in Europe and America. A Systematic Review. Eur. J. Psychol. Appl. Legal Context 2018, 10, 15–25. [Google Scholar] [CrossRef]
  22. Quevedo-Blasco, R.; Pérez, M.J.; Guillén-Riquelme, A.; Hess, T. Civil Liability for Clinical Misdiagnosis of Suicidal Intention: Procedure and Guidelines to Minimize Fatal Diagnostic Error. Eur. J. Psychol. Appl. Legal Context 2023, 15, 73–81. [Google Scholar] [CrossRef]
  23. Burke, B.L.; Martens, A.; Faucher, E.H. Two Decades of Terror Management Theory: A Meta-Analysis of Mortality Salience Research. Pers. Soc. Psychol. Rev. 2010, 14, 155–195. [Google Scholar] [CrossRef]
  24. Chatard, A.; Hirschberger, G.; Pyszczynski, T. A word of caution about Many Labs 4: If you fail to follow your preregistered plan, you may fail to find a real effect. ML4 Reanalysis 2020, 1–13. Available online: https://osf.io/preprints/psyarxiv/ejubn (accessed on 11 October 2023).
  25. Blomstrom, M.; Burns, A.; Larriviere, D.; Penberthy, J.K. Addressing fear of death and dying: Traditional and innovative interventions. Mortality 2020, 27, 18–37. [Google Scholar] [CrossRef]
  26. Grossman, C.H.; Brooker, J.; Michael, N.; Kissane, D. Death anxiety interventions in patients with advanced cancer: A systematic review. Palliat. Med. 2017, 32, 172–184. [Google Scholar] [CrossRef]
  27. Soleimani, M.A.; Lehto, R.H.; Negarandeh, R.; Bahrami, N.; Nia, H.S. Relationships between death anxiety and quality of life in Iranian patients with cancer. Asia-Pac. J. Oncol. Nur. 2016, 3, 183–191. [Google Scholar] [CrossRef]
  28. Soleimani, M.A.; Lehto, R.H.; Negarandeh, R.; Bahrami, N.; Chan, Y.H. Death Anxiety and Quality of Life in Iranian Caregivers of Patients with Cancer. Cancer Nurs. 2017, 40, e1–e10. [Google Scholar] [CrossRef] [PubMed]
  29. Boeschoten, R.E.; Braamse, A.M.; Beekman, A.T.; Cuijpers, P.; van Oppen, P.; Dekker, J.; Uitdehaag, B.M. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J. Neurol. Sci. 2017, 372, 331–341. [Google Scholar] [CrossRef] [PubMed]
  30. Francalancia, J.; Mavrogiorgou, P.; Juckel, G.; Mitrovic, T.; Kuhle, J.; Naegelin, Y.; Kappos, L.; Calabrese, P. Death Anxiety and Attitudes towards Death in Patients with Multiple Sclerosis: An Exploratory Study. Brain Sci. 2021, 11, 964. [Google Scholar] [CrossRef] [PubMed]
  31. Nia, H.S.; Lehto, R.H.; Ebadi, A.; Peyrovi, H. Death Anxiety among Nurses and Health Care Professionals: A Review Article. Int. J. Community Based Nurs. Midwifery 2016, 4, 2–10. [Google Scholar]
  32. Ghazanfari, M.J.; Chaghian Arani, R.; Mollaei, A.; Mollaei, A.; Falakdami, A.; Takasi, P.; Ghorbani Vajargah, P.; Esmaeili, S.H.; Jafari, H.; Yaghoubi, T.; et al. Death Anxiety and Related Factors among nurses during the COVID-19 Pandemic: A Systematic Review. Jorjani Biomed. J. 2022, 10, 35–42. [Google Scholar]
  33. Matsui, M.; Braun, K. Nurses’ and care workers’ attitudes toward death and caring for dying older adults in Japan. Int. J. Palliat. Nurs. 2010, 16, 593–598. [Google Scholar] [CrossRef]
  34. Semenova, V.; Stadtlander, L. Death Anxiety, Depression, and Coping in Family Caregivers. J. Soc. Behav. Health Sci. 2016, 10, 34–48. [Google Scholar] [CrossRef]
  35. Grabler, M.R.; Weyen, U.; Juckel, G.; Tegenthoff, M.; Mavrogiorgou-Juckel, P. Death Anxiety and Depression in Amyotrophic Lateral Sclerosis Patients and Their Primary Caregivers. Front. Neurol. 2018, 9, 1035. [Google Scholar] [CrossRef] [PubMed]
  36. Caregiver Statistics: Health, Technology, and Caregiving Resources. Available online: https://www.caregiver.org/resource/caregiver-statistics-health-technology-and-caregiving-resources/ (accessed on 2 January 2023).
  37. Caregiver Statistics: Work and Caregiving. Available online: https://www.caregiver.org/resource/caregiver-statistics-work-and-caregiving/ (accessed on 2 January 2023).
  38. Yalom, I.D. Existential Psychotherapy; Basic Books: New York, NY, USA, 1980. [Google Scholar]
  39. Neimeyer, R.A.; Wittkowski, J.; Moser, R.P. Psychological research on death attitudes: An overview and evaluation. Death Stud. 2004, 28, 309–340. [Google Scholar] [CrossRef]
  40. Applebaum, A.J.; Kryza-Lacombe, M.; Buthorn, J.; DeRosa, A.; Corner, G.; Diamond, E.L. Existential distress among caregivers of patients with brain tumors: A review of the literature. Neuro-Oncol. Pract. 2015, 3, 232–244. [Google Scholar] [CrossRef] [PubMed]
  41. Cervantes, L.; Carr, A.L.; Welles, C.C.; Zoucha, J.; Steiner, J.F.; Johnson, T.; Earnest, M.; Camacho, C.; Suresh, K.; Hasnain-Wynia, R. The Experience of Primary Caregivers of Undocumented Immigrants with End-Stage Kidney Disease that Rely on Emergency-Only Hemodialysis. J. Gen. Intern. Med. 2020, 35, 2389–2397. [Google Scholar] [CrossRef] [PubMed]
  42. Perestelo-Pérez, L. Standards on how to develop and report systematic reviews in Psychology and Health. Int. J. Clin. Health Psychol. 2013, 13, 49–57. [Google Scholar] [CrossRef]
  43. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J. Clin. Epidemiol. 2021, 134, 178–189. [Google Scholar] [CrossRef]
  44. Quevedo-Blasco, R. Guía Aplicada Sobre Cómo Buscar Información en Investigación. Herramientas y Aspectos Básicos; Independently Published; 2022. [Google Scholar]
  45. Moola, S.; Munn, Z.; Tufanaru, C.; Aromataris, E.; Sears, K.; Sfetcu, R.; Currie, M.; Qureshi, R.; Mattis, P.; Lisy, K.; et al. Systematic reviews of etiology and risk. In JBI Manual for Evidence Synthesis; Aromataris, E., Munn, Z., Eds.; University of Adelaide: Adelaide, Australia, 2020. [Google Scholar]
  46. Lau, B.H.P.; Wong, D.F.; Fung, Y.; Zhou, J.; Chan, C.L.; Chow, A.Y. Facing death alone or together? Investigating the interdependence of death anxiety, dysfunctional attitudes, and quality of life in patient-caregiver dyads confronting lung cancer. Psycho-Oncol. 2018, 27, 2045–2051. [Google Scholar] [CrossRef]
  47. Onyechi, K.; Onuigbo, L.; Eseadi, C.; Ikechukwu-Ilomuanya, A.; Nwaubani, O.; Umoke, P.; Agu, F.; Otu, M.; Utoh-Ofong, A. Effects of Rational-Emotive Hospice Care Therapy on Problematic Assumptions, Death Anxiety, and Psychological Distress in a Sample of Cancer Patients and Their Family Caregivers in Nigeria. Int. J. Environ. Res. Public Health 2016, 13, 929. [Google Scholar] [CrossRef]
  48. Barker, T.H.; Stone, J.C.; Sears, K.; Klugar, M.; Tufanaru, C.; Leonardi-Bee, J.; Aromataris, E.; Munn, Z. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid. Synth. 2023, 21, 494–506. [Google Scholar] [CrossRef]
  49. Cobos-Carbó, A.; Augustovski, F. Declaración CONSORT 2010: Actualización de la lista de comprobación para informar ensayos clínicos aleatorizados de grupos paralelos. Med. Clin. 2011, 137, 213–215. [Google Scholar] [CrossRef] [PubMed]
  50. Alkan, A.; Köksoy, E.B.; Karci, E.; Alkan, A.; Bruera, E.; Çay Şenley, F. Posttraumatic growth and death anxiety in caregivers of cancer patients: PHOENIX study. Turk. J. Med. Sci. 2020, 50, 1364–1370. [Google Scholar] [CrossRef] [PubMed]
  51. Templer, D.I. The Construction and Validation of a Death Anxiety Scale. J. Gen. Psychol. 1970, 82, 165–177. [Google Scholar] [CrossRef] [PubMed]
  52. Bachner, Y.G.; O’Rourke, N.; Carmel, S. Fear of Death, Mortality Communication, and Psychological Distress Among Secular and Religiously Observant Family Caregivers of Terminal Cancer Patients. Death Stud. 2011, 35, 163–187. [Google Scholar] [CrossRef] [PubMed]
  53. Carmel, S. The will to live: Gender differences among elderly persons. Soc. Sci. Med. 2001, 52, 949–958. [Google Scholar] [CrossRef] [PubMed]
  54. Braun, S.E.; Aslanzadeh, F.J.; Thacker, L.; Loughan, A.R. Examining fear of cancer recurrence in primary brain tumor patients and their caregivers using the Actor-Partner Interdependence Model. Psycho-Oncology 2021, 30, 1120–1128. [Google Scholar] [CrossRef] [PubMed]
  55. Juckel, G.; Mavrogiorgou, P. Die Angst vor dem Tod und ihre Bedeutung für die Psychiatrie [Death anxiety and its importance for psychiatry]. Fortschr. Neurol. Psychiatr. 2017, 86, 226–232. [Google Scholar]
  56. Conte, H.R.; Weiner, M.B.; Plutchik, R. Measuring death anxiety: Conceptual, psychometric, and factor-analytic aspects. J. Pers. Soc. Psychol. 1982, 43, 775–785. [Google Scholar] [CrossRef]
  57. Seyedoshohadaee, M.; Bozorgi Matin, M.; Haghani, H. Association of Death Anxiety and Quality of Life in the Caregivers of Patients with Multiple Sclerosis. Iran. J. Nurs. Res. 2019, 32, 1–13. [Google Scholar] [CrossRef]
  58. Sherman, D.W.; Norman, R.; McSherry, C.B. A Comparison of Death Anxiety and Quality of Life of Patients with Advanced Cancer or AIDS and Their Family Caregivers. J. Assoc. Nurses AIDS Care 2010, 21, 99–112. [Google Scholar] [CrossRef]
  59. Uslu-Sahan, F.; Terzioglu, F.; Koc, G. Hopelessness, Death Anxiety, and Social Support of Hospitalized Patients with Gynecologic Cancer and Their Caregivers. Cancer Nurs. 2019, 42, 373–380. [Google Scholar] [CrossRef] [PubMed]
  60. Thorson, J.A.; Powell, F.C. A revised death anxiety scale. Death Stud. 1992, 16, 507–521. [Google Scholar] [CrossRef]
  61. Willis, K.; Ravyts, S.G.; Lanoye, A.; Reid, M.P.; Aslanzadeh, F.J.; Braun, S.E.; Svikis, D.; Rodin, G.; Loughan, A.R. Measuring and understanding death anxiety in caregivers of patients with primary brain tumor. Palliat. Support. Care 2022, 1–8. [Google Scholar] [CrossRef] [PubMed]
  62. Lo, C.; Hales, S.; Zimmermann, C.; Gagliese, L.; Rydall, A.; Rodin, G. Measuring Death-Related Anxiety in Advanced Cancer. J. Pediatr. Hematol. Oncol. 2011, 33, S140–S145. [Google Scholar] [CrossRef] [PubMed]
  63. Soleimani, M.A.; Bahrami, N.; Allen, K.A.; Alimoradi, Z. Death anxiety in patients with cancer: A systematic review and meta-analysis. Eur. J. Oncol. Nurs. 2020, 48, 101803. [Google Scholar] [CrossRef] [PubMed]
  64. Soleimani, M.A.; Pahlevan Sharif, S.; Allen, K.A.; Yaghoobzadeh, A.; Sharif Nia, H.; Gorgulu, O. Psychometric Properties of the Persian Version of Spiritual Well-Being Scale in Patients with Acute Myocardial Infarction. J. Relig. Health 2016, 56, 1981–1997. [Google Scholar] [CrossRef] [PubMed]
  65. Tirado, G.; Rodríguez-Cifuentes, F.; Llorente-Alonso, M.; Rubio-Garay, F.; Topa, G.; López-González, M.A. Desequilibrio Esfuerzo-Recompensa y quejas subjetivas de salud: Un modelo de mediación moderada con profesionales sanitarios. Rev. Iberoam. Psicol. Salud 2022, 13, 93–103. [Google Scholar]
  66. Abdel-Khalek, A.M.; Neimeyer, R.A. Death Anxiety Scale. Encyclopedia of Personality and Individual Differences; Springer: Cham, Switzerland, 2017. [Google Scholar]
  67. Eshbaugh, E.; Henninger, W. Potential mediators of the relationships between gender and death anxiety. Individ. Differ. Res. 2013, 11, 22–30. [Google Scholar]
  68. Russac, R.J.; Gatliff, C.; Reece, M.; Spottswood, D. Death Anxiety across the Adult Years: An Examination of Age and Gender Effects. Death Stud. 2007, 31, 549–561. [Google Scholar] [CrossRef]
  69. Götze, H.; Brähler, E.; Gansera, L.; Schnabel, A.; Gottschalk-Fleischer, A.; Köhler, N. Anxiety, depression and quality of life in family caregivers of palliative cancer patients during home care and after the patient’s death. Eur. J. Cancer Care 2016, 27, e12606. [Google Scholar] [CrossRef]
  70. Leibach, G.G.; Stern, M.; Aguayo Arelis, A.; Macias Islas, M.M.; Rábago Barajas, B.V. Mental Health and Health-Related Quality of Life in Multiple Sclerosis Caregivers in Mexico. Int. J. MS Care 2016, 18, 19–26. [Google Scholar] [CrossRef] [PubMed]
  71. Özönder Ünal, I.; Ordu, C. Decoding Caregiver Burden in Cancer: Role of Emotional Health, Rumination, and Coping Mechanisms. Healthcare 2023, 11, 2700. [Google Scholar] [CrossRef] [PubMed]
  72. Ndlovu, J.T.; Mokwena, K.E. Burden of Care of Family Caregivers for People Diagnosed with Serious Mental Disorders in a Rural Health District in Kwa-Zulu-Natal, South Africa. Healthcare 2023, 11, 2686. [Google Scholar] [CrossRef] [PubMed]
  73. Xia, C.; Wei, T.; Tang, Q.; Zheng, H.; Chen, G.; Lu, J. Depression and Associated Factors among Family Caregivers of Children with Disabilities: Analysis of Intergenerational Differences. Healthcare 2023, 11, 2693. [Google Scholar] [CrossRef] [PubMed]
  74. Alcántara-Jiménez, M.; Torres-Parra, I.; Guillén-Riquelme, A.; Quevedo-Blasco, R. Los factores psicosociales en el suicidio de presos en prisiones europeas: Una revisión sistemática y meta-análisis. Anu. Psicol. Jurid. 2023, 33, 101–114. [Google Scholar] [CrossRef]
  75. Romero-Lara, P.R.; Guillén-Riquelme, A.; Quevedo-Blasco, R. Perfil psicosocial, factores de riesgo y reinserción en reclusas adultas: Una revisión sistemática. Rev. Latinoam. Psicol. 2020, 52, 193–217. [Google Scholar] [CrossRef]
  76. Quevedo-Blasco, R.; Llavat, S.; Palomares-Rodríguez, J.M.; Rodríguez-Díaz, F.J. Clima emocional y burnout en funcionarios de instituciones penitenciarias andaluzas. Rev. Iberoam. Justicia Ter. 2023, 6, 749. [Google Scholar]
  77. Quevedo-Blasco, R.; Palomares-Rodríguez, J.M. Evolución histórica del perfil profesional de las víctimas de suicidio en España (1943–2005). Rev. Int. Comp. Relac. Laborales Derecho Empl. 2023, 11, 298–312. [Google Scholar]
  78. Badenes-Sastre, M.; Lorente, M.; Expósito, F. Future health-professionals: Attitudes, perceived severity, and willingness to intervene in intimate partner violence cases. Rev. Iberoam. Psicol. Salud 2023, 14, 10–17. [Google Scholar] [CrossRef]
  79. Ruiz-Herrera, N.; Díaz-Román, A.; Guillén-Riquelme, A.; Quevedo-Blasco, R. Sleep Patterns during the COVID-19 Lockdown in Spain. Int. J. Environ. Res. Public Health 2023, 20, 4841. [Google Scholar] [CrossRef]
Healthcare 12 00107 g001
Figure 1. Flow Diagram of the Study Selection Process.
Figure 1. Flow Diagram of the Study Selection Process.
Healthcare 12 00107 g001
Healthcare 12 00107 g002
Figure 2. Forest Plot of the Comparison of Death Anxiety between Patients and Caregivers [35,46,47,54,58,59].
Figure 2. Forest Plot of the Comparison of Death Anxiety between Patients and Caregivers [35,46,47,54,58,59].
Healthcare 12 00107 g002
Table 1. Main Characteristics and Outcomes of the Included Studies.
Table 1. Main Characteristics and Outcomes of the Included Studies.
Authors (Year)CountryN (% Females)InstrumentsResults
Alkan et al. (2020) [50]Turkey426 (50.23)
Median age = 40.5 (17–70)		Templer’s DAS [51]
▫
Moderate anxiety in caregivers: Mean = 8 (0–15)
Bachner et al. (2011) [52]Israel236: 142 secular (75.35; mean age = 55.31, SD = 13.78) and 94 religious (80.85; mean age = 55.45, SD = 13.64)Carmel’s Fear of Death and Dying Inventory [53]
▫
Low anxiety in secular caregivers: Mean = 1.89 (0–5)
▫
Medium anxiety in religious caregivers: Mean = 2.26 (0–5)
Braun et al. (2021) [54]USA52 (59.62)
Mean age = 56.6 (34–79)		Templer’s DAS [51]
▫
Moderate anxiety in caregivers: Mean = 6.08 (0–15)
▫
No differences between patients and caregivers
Grabler et al. (2018) [35]Germany30 (53.33)
Mean age = 57.33 (SD = 9.47)		BOFRETTA Scale [55]
▫
Moderate anxiety in caregivers: Mean = 23.5 (10–40)
▫
No differences between patients and caregivers
Lau et al. (2018) [46]Japan173 (53.8)
Mean age = 53.2 (SD = 12.6)		Templer’s DAS [51]
▫
Moderate anxiety in caregivers: Mean = 7.65 (0–15)
▫
No differences between patients and caregivers
Onyechi et al. (2016) [47]Nigeria52: 26 GT (84.62; mean age = 55.75, SD = 3.03) and 26 GC (84.62; mean age = 55.74, SD = 3.05)DAQ [56]
▫
High anxiety at baseline in caregivers of the GT (mean = 71; 15–75) and the GC (mean = 70.69; 15–75)
Seyedoshohadaee et al. (2019) [57]Iran200 (41.50)
Mean age = 40.39 (SD = 11.75)		Templer’s DAS [51]
▫
Moderate anxiety in caregivers: Mean = 5.92 (0–15)
Sherman et al. (2010) [58]USA79: 43 AIDS (67.44; mean age = 42.4, SD = 13.6) and 36 cancer (61.11; mean age = 56, SD = 14.8)DAQ [56]
▫
No differences in death anxiety between caregivers of AIDS and cancer patients a
▫
No correlations between scores of patients and caregivers
Soleimani et al. (2017) [28]Iran330 (58.79)
Mean age = 40 (SD = 13.5)		Templer’s DAS [51]
▫
Moderate anxiety in caregivers: Mean = 46.7 (15–75) b
Uslu-Sahan et al. (2019) [59]Turkey200 (71.00)
Mean age = NS
(55.5% < 45 years)		Thorson-Powell’s DAS [60]
▫
Moderate anxiety in caregivers: Mean = 46.83 (0–100)
▫
Higher anxiety in patients than in caregivers
Willis et al. (2022) [61]USA67 (73.13)
Mean age = 50.61 (SD = 13.56)		DADDS-CG [62]
▫
Moderate anxiety in caregivers: Mean = 34.81 (0–75)
Notes. SD, standard deviation; NS, not specified; DAS, Death Anxiety Scale; GT, treatment group; GC, control group; DAQ, Death Anxiety Questionnaire; DADDS-CG, Death and Dying Distress Scale-Caregivers; AIDS, Acquired Immune Deficiency Syndrome. a Only the total sample was considered for the meta-analysis, without differentiation between the caregivers of the two patient groups, based on the data provided by the authors of the article concerning the total scale score. b The scoring range in this study (15–75) is higher than in other studies (0–15) due to the specific version of the Templer’s DAS used in this study (the Persian version).
Table 2. Other Outcomes of the Included Studies.
Table 2. Other Outcomes of the Included Studies.
Authors (Year)DiseaseVariables Associated with Death AnxietyInstruments
Alkan et al. (2020) [50]Cancer (gastrointestinal, breast, lung, prostate, gynecological, other)(+) Posttraumatic growth, female sex, self-perception, philosophy of life, and changes in relationship
▫
Post-Traumatic Growth Inventory & Scale (PTGI)
▫
Questionnaries on demographic data and sociocultural background
Bachner et al. (2011) [52]Cancer (NS)(+) Depressive symptomatology in religious caregivers
(−) Emotional exhaustion in secular caregivers
▫
Abridged Beck Depression Inventory (BDI)
▫
Exhaustion subscale of the Maslach Burnout Inventory (MBI)
Braun et al. (2021) [54]Brain tumor(+) Fear of cancer recurrence in patients and caregivers
▫
Fear of Cancer Recurrence (FCR-7)
Grabler et al. (2018) [35]ALS(+) Caregivers’ depression with patients’ death anxiety
(+) Anxiety in caregivers, and depression in both patients and caregivers
▫
Beck Depression Inventory (BDI)
▫
State-Trait Anxiety Inventory (STAI)
Lau et al. (2018) [46]Lung cancer(+) Achievement and dependency in patients and caregivers
(−) Quality of life in patients, and self-control in both patients and caregivers
▫
Dysfunctional Attitude Scale (DAS)
▫
Caregiver Quality of Life Index—Cancer (CQOLC)
Onyechi et al. (2016) [47]Cancer (breast, prostate, cervix)Beneficial effects of Rational-Emotive Hospice Care Therapy (REHCT) on death anxiety in patients and caregivers
▫
REBT Hospice Care Manual
Seyedoshohadaee et al. (2019) [57]MS(+) Relationship with the patient, duration of patient care, occupational status, and type of insurance
(−) Quality of life
▫
Questionnaire on demographic characteristics
▫
36-Item Short Form Health Survey (SF-36)
Sherman et al. (2010) [58]Advanced cancer/AIDS(−) Quality of life in patients and caregivers
▫
Quality of Life Scale (Family Version) (QLS)
▫
McGill Quality of Life Questionnaire (MQOL)
Soleimani et al. (2017) [28]Cancer (NS)(+) Caregiver demographic factors (being a daughter, female sex, unemployment, education level, and having family as main source of income) and patient factors (not having anticancer treatment and receiving radiation therapy)
(−) Social support, socioeconomic status, engagement in social activities, prayer frequency, and quality of life
▫
Sociodemographic survey
▫
Quality of Life Scale (Family Version) (QOL-FL)
Uslu-Sahan et al. (2019) [59]Gynecological cancer(−) Social support in patients and caregivers
▫
Multidimensional Perceived Social Support Scale (MSPSS)
Willis et al. (2022) [61]Brain tumor(+) Female sex and tumor grade
▫
Reports of sociodemographic information
▫
Medical records
Notes. ALS, Amyotrophic Lateral Sclerosis; MS, Multiple Sclerosis; NS, not specified; AIDS, Acquired Immune Deficiency Syndrome; (+), positive relationship; (−), negative relationship.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Quevedo-Blasco, R.; Díaz-Román, A.; Vega-García, A. Death Anxiety in Caregivers of Chronic Patients. Healthcare 2024, 12, 107. https://doi.org/10.3390/healthcare12010107

AMA Style

Quevedo-Blasco R, Díaz-Román A, Vega-García A. Death Anxiety in Caregivers of Chronic Patients. Healthcare. 2024; 12(1):107. https://doi.org/10.3390/healthcare12010107

Chicago/Turabian Style

Quevedo-Blasco, Raúl, Amparo Díaz-Román, and Alberto Vega-García. 2024. "Death Anxiety in Caregivers of Chronic Patients" Healthcare 12, no. 1: 107. https://doi.org/10.3390/healthcare12010107

APA Style

Quevedo-Blasco, R., Díaz-Román, A., & Vega-García, A. (2024). Death Anxiety in Caregivers of Chronic Patients. Healthcare, 12(1), 107. https://doi.org/10.3390/healthcare12010107

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop